Mitogen-inducible gene-6 expression correlates with survival and is an independent predictor of recurrence in BRAFV600E positive papillary thyroid cancers

This publication has 20 references indexed in Scilit:

• BRAF Mutation in Papillary Thyroid Cancer: Pathogenic Role, Molecular Bases, and Clinical Implications
  Endocrine Reviews, 2007
• The Prevalence and Prognostic Value of BRAF Mutation in Thyroid Cancer
  Annals of Surgery, 2007
• RET/PTC Rearrangements and BRAF Mutations in Thyroid Tumorigenesis
  Endocrinology, 2007
• Mig-6, Signal Transduction, Stress Response and Cancer
  Cell Cycle, 2007
• Differentiated thyroid cancer cell invasion is regulated through epidermal growth factor receptor-dependent activation of matrix metalloproteinase (MMP)-2/gelatinase A
  Endocrine-Related Cancer, 2006
• Evidence that MIG-6 is a tumor-suppressor gene
  Oncogene, 2006
• Mig6 is a negative regulator of EGF receptor–mediated skin morphogenesis and tumor formation
  Nature Medicine, 2006
• ErbB Receptor Negative Regulatory Mechanisms: Implications in Cancer
  Journal of Mammary Gland Biology and Neoplasia, 2006
• Gene 33 Is an Endogenous Inhibitor of Epidermal Growth Factor (EGF) Receptor Signaling and Mediates Dexamethasone-induced Suppression of EGF Function
  Journal of Biological Chemistry, 2005
• Epidermal growth factor enhances proliferation, migration, and invasion of follicular and papillary thyroid cancer in vitro and in vivo
  The Journal of Clinical Endocrinology & Metabolism, 1994